text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 52214-84-3 | Product Number: C2667

Ciprofibrate


Purity: >98.0%(GC)(T)
Synonyms:
  • 2-[4-(2,2-Dichlorocyclopropyl)phenoxy]-2-methylpropionic Acid
Product Documents:
1G
€56.00
1   3  
5G
€179.00
1   7  

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number C2667
Purity / Analysis Method >98.0%(GC)(T)
Molecular Formula / Molecular Weight C__1__3H__1__4Cl__2O__3 = 289.15 
Physical State (20 deg.C) Solid
Storage Temperature Refrigerated (0-10°C)
Condition to Avoid Heat Sensitive
CAS RN 52214-84-3
Reaxys Registry Number 1984981
PubChem Substance ID 160871346
Merck Index (14) 2313
MDL Number

MFCD00467135

Specifications
Appearance White to Light yellow powder to crystal
Purity(GC) min. 98.0 %
Purity(Neutralization titration) min. 98.0 %
Melting point 116.0 to 120.0 °C
NMR confirm to structure
Properties (reference)
Melting Point 118 °C
Solubility (soluble in) Methanol
GHS
Related Laws:
EC Number 257-744-6
RTECS# UF0880000
Transport Information:
HS Number 2918999090
Application
Clofibrate: Antilipemic with Activity against Peroxisome Proliferator-Activated Receptors (PPARs)

The fibrates, including ciprofibrate, are lower elevated serum lipids by decreasing the low density lipoprotein (LDL) fraction rich in cholesterol and the very low density lipoprotein (VLDL) fraction rich in triglycerides. In addition, fibrates increase the high density lipoprotein (HDL) cholesterol fraction. The precise mechanisms of action remain unknown, but it has been reported that the major modes of action of the fibrates as follows: VLDL catabolism by increased lipoprotein and hepatic triglyceride lipase activities; suppression of triglyceride biosynthesis by acetyl-CoA carboxylase enzyme inhibition and attenuation of cholesterol biosynthesis by inhibition of the rate-limiting HMG-CoA reductase.
Since the late 1990s, it has been reported that fibrates activate specific transcription factors belonging to the nuclear hormone receptor superfamily, termed peroxisome proliferator-activated receptors (PPARs) which activation increases HDL cholesterol synthesis, stimulates "reverse" cholesterol transport and reduces triglycerides. (The product is for research purpose only.)

References


Application
Studies on Peroxisome Proliferator-Activated Receptors (PPARs)

References


PubMed Literature


TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.